We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Walmart Inc | NYSE:WMT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.85 | 1.44% | 59.70 | 59.885 | 58.58 | 58.98 | 17,784,103 | 22:47:10 |
From May 2021 to May 2024
By Dave Sebastian
Walmart Inc. said it launched a private-brand analog insulin, with Novo Nordisk A/S-made insulin aspart injections available in the retail giant's pharmacies this week.
The injections are available through Walmart's private ReliOn brand, with analog insulin vials retailing at $72.88 and FlexPen at $85.88, the company said Tuesday.
The insulin aspart injection will be available in Sam's Club pharmacies in mid-July across the U.S., Walmart said. Customers will need a prescription to buy the products, the company said.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
June 29, 2021 08:54 ET (12:54 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Walmart Chart |
1 Month Walmart Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
